Today Voted for Strong Nation and Strong leadership.
💪Strong leadership = Strong Nation 🇮🇳 .
Captain Matters .

The waiting time to see qualified oncologist in India 🇮🇳 varies from few hours ( for all major cities ) to may be a day or two for any remote corner of the country .Access to oncologist is not a issue for us .
Cost of therapy and affordable treatment is main issue .

@LARVOL OCNO DATA PODCAST | PRE-ASCO with Dr Amol Akhade x.com/i/broadcasts/1…

USFDA rejects another China 🇨🇳 Made IO inspite of wide separation of OS curves . Camrelizumb plus Rivoceranib combination for Advanced HCC is rejected by U.S. FDA . Free HOME Run for Atezolizumab plus bev ? 🤔 Tanios Bekaii-Saab, MD Axel Grothey

Tarlatamab. Anti -DLL3 BiTE got accelerated approval for extensive stage SCLC . Based upon Delphi-301 study , phase 2 .
Approved dose is 1 mg on cycle 1 day 1 and 10 mg on cycle 1 day 8 and 15 and then every 2 weekly .

Time to BiTE SCLC #LCSM U.S. FDA IASLC

Congrats 🍾🎉 to Hope Rugo on the #ESMOBreast24 award and lecture!

Your contributions to patients and the #bcsm is something to be very proud of!

#bcsm
#ESMOAmbassadors
ESMO - Eur. Oncology

Common side effects and need for monitoring , while using cdk 4 /6 inhibitors . Useful for practicing oncologist. ESMO - Eur. Oncology OncoAlert Oncology Brothers #esmobreast24

ADC and toxicity in Breast cancer. Useful for clinical practice. ESMO - Eur. Oncology OncoAlert #esmobreast24

Checkmate 77T. Perioperative Nivolumab in early stage resectable NSCLC. EFS benifit as per Stage and PDL1 expression. Subsequent therapies for both arms . How much additional benifit this gives over only neo adjuvant nivo . We don't know. NEJM

ADC plus IO . Slowly we are moving towards this in advanced breast cancer. Dr Sarah Sammons Sara Tolaney ESMO - Eur. Oncology OncoAlert #esmobreast24

Can Atezo work in TNBC pts who have early relapse ? NO . Impassion 132 is negative. ESMO - Eur. Oncology OncoAlert #esmobreast24

The eternal question. Can we give olaparib and abemaciclib both for adjuvant treatment in ER postive Her2 negative EBC with Brca postive- if u can manage toxicity, u can discuss- data for OS for this subset is not yet matured ESMO - Eur. Oncology OncoAlert Erika Hamilton, MD Oncology Brothers

De escalation strategy for her2 postive EBC . HER2Dx score can be useful. Kevin Punie Erika Hamilton, MD OncoAlert ESMO - Eur. Oncology #esmobreast24

TNBC - neo adjuvant and adjuvant treatment. Clinical pearls . Excellent summary. ESMO - Eur. Oncology OncoAlert Oncology Brothers Erika Hamilton, MD #esmobreast24

Significance of PCR , RCB ,
CPS -EG score , TILs in EBC treatment. ESMO - Eur. Oncology #esmobreast24 OncoAlert Erika Hamilton, MD

Personalized medicine in early breast cancer- where we are and where we are heading-
Do u think ctDNA based monitoring will be realistic In EBC in near future? Some data from monarchE to support . Erika Hamilton, MD Dr Sarah Sammons Sara Tolaney ESMO - Eur. Oncology #esmobreast24

Important points about Her2 low and ultra low reporting in clinical practice. Useful for clinical practice especially , for pathologist and oncologist ESMO - Eur. Oncology #esmobreast24

Sotorasib dosing issue is getting attention and rightly so . 240 mg is the right dose and @usfda should remove the approval for higher dose ( 960 mg ) Vinay Prasad MD MPH

Diminishing role of surgery in pleural mesothelioma? MARS2, phase 3 RCT has shown that extended pleurectomy decortication was associated with worse survial to 2 years and more serious adverse events for individuals with resectable pleural mesothelioma, compared to

One more trial to show that u can not give IO drugs along with Chemoradiation in stage IIIB NSCLC . Checkmate 73L . Concurrent Nivo plus cCRT followed by Nivo plus IPI or Nivo alone vs Pacific arm ( cCRT followed by Durva ) failed to show PFS benifit. Press release.